Moreover, in breast cancer cells, TXNRD1 overregulation, by inducing epithelial-to-mesenchymal transition (EMT), enhanced invasiveness, thus being considered a candidate for therapeutic targeting [57]. This evidence concerns the gene TXNRD1 and breast carcinoma.